Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CARL E DUKES

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1154334464
CMS profile
323948
Location
SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$11,182.29

131 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 3 of 3; records 101–131 of 131 matching records. This page contains 31 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CARL E DUKES

NPI 1154334464 · CMS profile ID 323948

Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology

SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–131 of 131 matching records. This page contains 31 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1154334464?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CARL E DUKES, NPI 1154334464, CMS profile ID 323948. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–131 of 131 matching records. This page contains 31 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1154334464?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). CARL E DUKES, NPI 1154334464, CMS profile ID 323948. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–131 of 131 matching records. This page contains 31 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1154334464?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
CARL E DUKES, NPI 1154334464, CMS profile ID 323948, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–131 of 131 matching records. This page contains 31 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1154334464?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

131 matching records · $11,182.29 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 131 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–131 of 131.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Travere Therapeutics, Inc. $23.3903/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149942978 CMS
AstraZeneca Pharmaceuticals LP $100.0003/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110536800 CMS
Fresenius USA Marketing, Inc. $23.6003/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154204692 CMS
Ardelyx, Inc. $21.5503/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146678815 CMS
AstraZeneca Pharmaceuticals LP $18.9703/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110537601 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.4903/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086228302 CMS
OPKO Pharmaceuticals, LLC $20.9703/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112844190 CMS
Amgen Inc. $125.0002/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111566487 CMS
AstraZeneca Pharmaceuticals LP $124.0002/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110534346 CMS
Ardelyx, Inc. $57.2702/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146678813 CMS
Lilly USA, LLC $33.3902/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136084298 CMS
Travere Therapeutics, Inc. $16.8902/22/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149942946 CMS
Travere Therapeutics, Inc. $16.8902/22/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149942950 CMS
Travere Therapeutics, Inc. $19.5702/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149942962 CMS
ANI Pharmaceuticals, Inc. $29.7402/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091134135 CMS
Vifor Pharma, Inc. $18.5402/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124046440 CMS
Bayer Healthcare Pharmaceuticals Inc. $28.3602/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086150845 CMS
AstraZeneca Pharmaceuticals LP $1,600.0002/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110539563 CMS
AstraZeneca Pharmaceuticals LP $11.3902/07/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110532477 CMS
AstraZeneca Pharmaceuticals LP $109.0102/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110554250 CMS
Novo Nordisk Inc $8.0102/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097698478 CMS
AstraZeneca Pharmaceuticals LP $15.0702/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110535040 CMS
OPKO Pharmaceuticals, LLC $7.1802/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112844188 CMS
Amgen Inc. $12.6002/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111566485 CMS
Novo Nordisk Inc $117.1202/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096845137 CMS
Lilly USA, LLC $16.0501/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136034436 CMS
Amgen Inc. $26.4801/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111566493 CMS
Novartis Pharmaceuticals Corporation $13.8301/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086938201 CMS
OPKO Pharmaceuticals, LLC $19.3001/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112844186 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.1901/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086178608 CMS
OPKO Pharmaceuticals, LLC $6.8601/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112844184 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $60,070.96 173
PY2020 $18,404.54 86
PY2021 $37,736.64 137
PY2022 $48,277.13 166
PY2023 $44,862.11 179
PY2024 $11,182.29 131
PY2025 $17,734.68 139

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $23,860.00 11
PY2024 Principal investigator $78,183.94 30
PY2023 Principal investigator $218,582.21 99
PY2022 Recipient $28,080.16 6
PY2022 Principal investigator $1,549,455.80 358
PY2021 Recipient $9,684.00 1
PY2021 Principal investigator $2,112,461.70 884
PY2020 Recipient $8,047.30 3
PY2020 Principal investigator $1,150,918.58 341
PY2019 Principal investigator $519,430.95 413

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 SANOFI US SERVICES INC. $6,050.00 09/15/2025 Non-covered Recipient Entity
Sun Research Inst LLC
Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of SAR440340/ REGN3500/ Itepekimab (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) No dispute reported 06/30/2026 1226138491
Principal investigator 1 SANOFI US SERVICES INC. $2,575.00 09/15/2025 Non-covered Recipient Entity
Sun Research Inst LLC
Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of SAR440340/ REGN3500/ Itepekimab (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) No dispute reported 06/30/2026 1226138520
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,500.00 07/03/2025 Non-covered Recipient Entity
SUN RESEARCH INSTITUTE LLC
EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS No dispute reported 06/30/2026 1232945653
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,619.00 04/23/2025 Non-covered Recipient Entity
SUN RESEARCH INSTITUTE LLC
EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS No dispute reported 06/30/2026 1232945253
Principal investigator 1 Vanda Pharmaceuticals Inc. $3,128.18 04/03/2025 Non-covered Recipient Entity
SUN RESEARCH INSTITUTE LLC
EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS No dispute reported 06/30/2026 1232945048
Principal investigator 1 Vanda Pharmaceuticals Inc. $888.18 04/03/2025 Non-covered Recipient Entity
SUN RESEARCH INSTITUTE LLC
EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS No dispute reported 06/30/2026 1232945053
Principal investigator 1 Vanda Pharmaceuticals Inc. $383.64 04/03/2025 Non-covered Recipient Entity
SUN RESEARCH INSTITUTE LLC
EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS No dispute reported 06/30/2026 1232945057
Principal investigator 1 Vanda Pharmaceuticals Inc. $550.00 04/03/2025 Non-covered Recipient Entity
SUN RESEARCH INSTITUTE LLC
EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS No dispute reported 06/30/2026 1232945061
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,240.00 03/12/2025 Non-covered Recipient Entity
SUN RESEARCH INSTITUTE LLC
EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS No dispute reported 06/30/2026 1232944968
Principal investigator 1 Vanda Pharmaceuticals Inc. $2,240.00 02/12/2025 Non-covered Recipient Entity
SUN RESEARCH INSTITUTE LLC
EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS No dispute reported 06/30/2026 1232944763
Principal investigator 1 Vanda Pharmaceuticals Inc. $686.00 01/08/2025 Non-covered Recipient Entity
SUN RESEARCH INSTITUTE LLC
EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS No dispute reported 06/30/2026 1232944528